Sleep, mood and eating habits in women with gestational diabetes
Looks at how sleep and lifestyle relate to blood sugar in gestational diabetes.
Key facts
- Who runs it
- University of Split, School of Medicine
- Where
- Croatia1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Maternal Sleep and Lifestyle, Metabolic Health, and Perinatal Outcomes in Gestational Diabetes
- Status
- Recruiting
- People taking part
- 100 people, planned
- Started
- 1 Nov 2025
- Expected to end
- 1 Jan 2030
- Type of study
- Observational, 2 groups
- Treatments tested
- Home-Based Glucose Monitoring
- Inpatient Glucose Monitoring
- Record updated
- 2 January 2026
Who can take part
The trial is looking for pregnant women with newly found gestational diabetes (diabetes that starts in pregnancy). It studies how sleep, mood and lifestyle relate to blood sugar and birth outcomes.
- Age
- 18 years or older
- Sex
- Women only
- Disease stage
- New diagnosis of gestational diabetes by IADPSG criteria, at 24-34 weeks of pregnancy when joining.
- Earlier treatment
- People who use sedatives or anxiety medicines long term cannot join.
- Main reasons for not taking part
- Type 1 or type 2 diabetes before the pregnancy
- Current preeclampsia (high blood pressure in pregnancy) or other major pregnancy problems
- Major mental health conditions that would get in the way of taking part
- Not able to fill in the questionnaires
- Planned birth outside the study's hospital network
This trial only enrols pregnant participants. The registry sentence this rests on: * Pregnant women aged 18 years or older
Show the full registry criteria (13)Hide the full registry criteria
Who can take part
- Pregnant women aged 18 years or older
- New diagnosis of gestational diabetes mellitus (GDM) according to IADPSG criteria
- Gestational age 24-34 weeks at enrollment
- Able to complete study questionnaires (sleep, anxiety, eating behavior, lifestyle)
- Able to provide informed consent
- For participants in the home-monitoring pathway: ability to use a smartphone and the FreeStyle Libre device
Who cannot take part
- Chronic use of sedatives or anxiolytic medications
- Pre-existing type 1 or type 2 diabetes mellitus
- Major psychiatric disorders interfering with participation
- Any condition judged by clinicians to interfere with participation or data reliability
- Current preeclampsia or major obstetric complications at enrollment
- Inability to complete questionnaires
- Planned delivery outside the study's hospital network
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Sex
- Gestational diabetes
This trial is currently available in Croatia.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this observational study is to learn how sleep quality, mental health, lifestyle behaviors, and metabolic markers are related to glucose control and pregnancy outcomes in women with gestational diabetes mellitus (GDM). The main questions it aims to answer are:
Read full original descriptionShow less
* Do differences in sleep quality, anxiety levels, and eating behaviors relate to differences in glycemic control in women with GDM? * Are maternal metabolic markers (such as glucose, liver enzymes, and lipid levels) associated with perinatal outcomes such as birth weight, cesarean delivery, and neonatal complications? * To compare women who undergo short inpatient glucose monitoring with women who undergo home-based digital glucose monitoring to see if the mode of monitoring is related to differences in sleep, mental health, metabolic profiles, or perinatal outcomes.
Participants will:
* Complete questionnaires on sleep, anxiety, lifestyle, and eating behaviors * Undergo routine laboratory testing, including metabolic and blood markers. * Have glucose monitored either during a short hospital stay or through home use of the FreeStyle Libre sensor. * Be followed from GDM diagnosis (24-34 weeks) until delivery to assess maternal and newborn outcomes
The 2 groups in the trial
- Group 1: Home-Based Digital Monitoring
Pregnant women with GDM who are managed as outpatients using a short (24-36 hour) period of home-based glucose monitoring with the FreeStyle Libre system. This pathway reflects routine clinical practice for women who can return for follow-up the next day and are able to use the digital device.
Treatment: Home-Based Glucose Monitoring
- Group 2: Hospital-Based Glucose Monitoring
Pregnant women with GDM who undergo short (24-hour) inpatient glucose monitoring according to standard hospital protocols. Allocation to this pathway follows clinical logistics (e.g., distance ≥80 km, island residence) and is not assigned by the research team.
Treatment: Inpatient Glucose Monitoring
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 3 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Integrated Assessment of Sleep, Mental Health, Lifestyle Behaviors, Metabolic Markers, and Perinatal Outcomes in Women With Gestational Diabetes Mellitus: A Prospective Cohort Study
- Plain-language title
- Sleep, mood and eating habits in women with gestational diabetesGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Criteria questions
- Built from NCT07314944, who can take part
- Record updated
- 2 January 2026